Message from CEO
We provide unparalleled value to collaborate with you to accelerate your efforts in developing new therapies.
The world continues evolving, particularly fast in health care, pharmaceuticals and medical devices. Never before have synergistic partnerships become such a critical component to pharmaceutical and biotech organizations for enhanced R&D productivities. Contract Research Organizations (CROs) play increasingly important roles in supporting these kinds of endeavors.
Pharmalegacy is proud to be a premier CRO partner to you that provides specialty pharmacology services. Our core competency resides in our extensive knowledge in generating and using effective animal models relevant to human diseases. It is through our top-notch expertise and high-quality operations that we provide unparalleled value to collaborate with you to accelerate your efforts in developing new therapies.
We believe in adding value. We deliver more than just a study report. We provide solutions and decision-enabling data to advance drug and medical device candidates.
We believe in systems. Pharmalegacy’s operations are all driven by systems, systems that ensure deliveries of high consistency, reproducibility and accuracy. These elements are the cornerstones of rigorous science.
We believe in innovation. Pharmalegacy’s scientists constantly challenge the state of affairs to maximize and differentiate our value.
We believe in a superior customer experience. Our goal is to achieve an A+ in every step of customer interaction throughout our working relationships and beyond.
We look forward to working with you.
Chief Executive Officer